VP of Research and Special Initiatives, Google
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Partner at New Enterprise Associates
Co-Founder and CEO, Wetpaint
The San Diego Biotechnology Network has organized a presentation by Dan Shoemaker, the chief technology officer at Fate Therapeutics, and Stephen Chang, the chief scientific officer of Stemgent. They will give a short talk on the industrialization of advanced technology for drug discovery and development based on induced pluripotent stem cells. More information and online registration is here.